1. Home
  2. ANGI vs BBNX Comparison

ANGI vs BBNX Comparison

Compare ANGI & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANGI
  • BBNX
  • Stock Information
  • Founded
  • ANGI 1995
  • BBNX 2015
  • Country
  • ANGI United States
  • BBNX United States
  • Employees
  • ANGI N/A
  • BBNX N/A
  • Industry
  • ANGI Advertising
  • BBNX Medical/Dental Instruments
  • Sector
  • ANGI Consumer Discretionary
  • BBNX Health Care
  • Exchange
  • ANGI Nasdaq
  • BBNX Nasdaq
  • Market Cap
  • ANGI 566.2M
  • BBNX 649.9M
  • IPO Year
  • ANGI 2017
  • BBNX 2025
  • Fundamental
  • Price
  • ANGI $15.97
  • BBNX $12.67
  • Analyst Decision
  • ANGI Hold
  • BBNX Strong Buy
  • Analyst Count
  • ANGI 8
  • BBNX 10
  • Target Price
  • ANGI $20.33
  • BBNX $25.20
  • AVG Volume (30 Days)
  • ANGI 1.3M
  • BBNX 467.2K
  • Earning Date
  • ANGI 08-05-2025
  • BBNX 07-29-2025
  • Dividend Yield
  • ANGI N/A
  • BBNX N/A
  • EPS Growth
  • ANGI N/A
  • BBNX N/A
  • EPS
  • ANGI 1.03
  • BBNX N/A
  • Revenue
  • ANGI $1,125,635,000.00
  • BBNX $69,830,000.00
  • Revenue This Year
  • ANGI N/A
  • BBNX $32.79
  • Revenue Next Year
  • ANGI $4.24
  • BBNX $36.59
  • P/E Ratio
  • ANGI $15.48
  • BBNX N/A
  • Revenue Growth
  • ANGI N/A
  • BBNX 38911.17
  • 52 Week Low
  • ANGI $10.88
  • BBNX $8.89
  • 52 Week High
  • ANGI $29.15
  • BBNX $24.50
  • Technical
  • Relative Strength Index (RSI)
  • ANGI 50.65
  • BBNX N/A
  • Support Level
  • ANGI $16.00
  • BBNX N/A
  • Resistance Level
  • ANGI $17.13
  • BBNX N/A
  • Average True Range (ATR)
  • ANGI 0.65
  • BBNX 0.00
  • MACD
  • ANGI 0.05
  • BBNX 0.00
  • Stochastic Oscillator
  • ANGI 48.67
  • BBNX 0.00

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: